Skip to main content
Top
Published in: Journal of Gastrointestinal Surgery 10/2012

01-10-2012 | Original Article

Tumor Infiltration in the Medial Resection Margin Predicts Survival After Pancreaticoduodenectomy for Pancreatic Ductal Adenocarcinoma

Authors: Yaojun Zhang, Adam E. Frampton, Patrizia Cohen, Charis Kyriakides, Jan J. Bong, Nagy A. Habib, Duncan R. C. Spalding, Raida Ahmad, Long R. Jiao

Published in: Journal of Gastrointestinal Surgery | Issue 10/2012

Login to get access

Abstract

Background

Microscopic tumor involvement (R1) in different surgical resection margins after pancreaticoduodenectomy (PD) for pancreatic ductal adenocarcinoma (PDAC) has been debated.

Methods

Clinico-pathological data for 258 patients who underwent PD between 2001 and 2010 were retrieved from a prospective database. The rates of R1 resection in the circumferential resection margin (pancreatic transection, medial, posterior, and anterior surfaces) and their prognostic influence on survival were assessed.

Results

For PDAC, the R1 rate was 57.1 % (48/84) for any margin, 31.0 % (26/84) for anterior surface, 42.9 % (36/84) for posterior surface, 29.8 % (25/84) for medial margin, and 7.1 % (3/84) for pancreatic transection margin. Overall and disease-free survival for R1 resections were significantly worse than those for R0 resection (17.2 vs. 28.7 months, P = 0.007 and 12.3 vs. 21.0 months, P = 0.019, respectively). For individual margins, only medial positivity had a significant impact on survival (13.8 vs. 28.0 months, P < 0.001), as opposed to involvement in the anterior (19.7 vs. 23.3 months, P = 0.187) or posterior margin (17.5 vs. 24.2 months, P = 0.104). Multivariate analysis demonstrated R0 medial margin was an independent prognostic factor (P = 0.002, HR = 0.381; 95 % CI 0.207–0.701).

Conclusion

The medial surgical resection margin is the most important after PD for PDAC, and an R1 resection here predicts poor survival.
Appendix
Available only for authorised users
Literature
1.
2.
go back to reference Vincent A, Herman J, Schulick R, Hruban RH, Goggins M (2011) Pancreatic cancer. Lancet 378: 607-620.PubMedCrossRef Vincent A, Herman J, Schulick R, Hruban RH, Goggins M (2011) Pancreatic cancer. Lancet 378: 607-620.PubMedCrossRef
3.
go back to reference Carpelan-Holmstrom M, Nordling S, Pukkala E, Sankila R, Luttges J, et al. (2005) Does anyone survive pancreatic ductal adenocarcinoma? A nationwide study re-evaluating the data of the Finnish Cancer Registry. Gut 54: 385-387.PubMedCrossRef Carpelan-Holmstrom M, Nordling S, Pukkala E, Sankila R, Luttges J, et al. (2005) Does anyone survive pancreatic ductal adenocarcinoma? A nationwide study re-evaluating the data of the Finnish Cancer Registry. Gut 54: 385-387.PubMedCrossRef
4.
go back to reference Alexakis N, Halloran C, Raraty M, Ghaneh P, Sutton R, et al. (2004) Current standards of surgery for pancreatic cancer. Br J Surg 91: 1410-1427.PubMedCrossRef Alexakis N, Halloran C, Raraty M, Ghaneh P, Sutton R, et al. (2004) Current standards of surgery for pancreatic cancer. Br J Surg 91: 1410-1427.PubMedCrossRef
5.
go back to reference Ghaneh P, Costello E, Neoptolemos JP (2007) Biology and management of pancreatic cancer. Gut 56: 1134-1152.PubMedCrossRef Ghaneh P, Costello E, Neoptolemos JP (2007) Biology and management of pancreatic cancer. Gut 56: 1134-1152.PubMedCrossRef
6.
go back to reference Pancreatic Section BSoG (2005) Guidelines for the management of patients with pancreatic cancer periampullary and ampullary carcinomas. Gut 54 Suppl 5: v1-16. Pancreatic Section BSoG (2005) Guidelines for the management of patients with pancreatic cancer periampullary and ampullary carcinomas. Gut 54 Suppl 5: v1-16.
7.
go back to reference Fatima J, Schnelldorfer T, Barton J, Wood CM, Wiste HJ, et al. (2010) Pancreatoduodenectomy for ductal adenocarcinoma: implications of positive margin on survival. Arch Surg 145: 167-172.PubMedCrossRef Fatima J, Schnelldorfer T, Barton J, Wood CM, Wiste HJ, et al. (2010) Pancreatoduodenectomy for ductal adenocarcinoma: implications of positive margin on survival. Arch Surg 145: 167-172.PubMedCrossRef
8.
go back to reference Chang DK, Johns AL, Merrett ND, Gill AJ, Colvin EK, et al. (2009) Margin clearance and outcome in resected pancreatic cancer. J Clin Oncol 27: 2855-2862.PubMedCrossRef Chang DK, Johns AL, Merrett ND, Gill AJ, Colvin EK, et al. (2009) Margin clearance and outcome in resected pancreatic cancer. J Clin Oncol 27: 2855-2862.PubMedCrossRef
9.
go back to reference Winter JM, Cameron JL, Campbell KA, Arnold MA, Chang DC, et al. (2006) 1423 pancreaticoduodenectomies for pancreatic cancer: A single-institution experience. J Gastrointest Surg 10: 1199-1210; discussion 1210-1191. Winter JM, Cameron JL, Campbell KA, Arnold MA, Chang DC, et al. (2006) 1423 pancreaticoduodenectomies for pancreatic cancer: A single-institution experience. J Gastrointest Surg 10: 1199-1210; discussion 1210-1191.
10.
go back to reference Raut CP, Tseng JF, Sun CC, Wang H, Wolff RA, et al. (2007) Impact of resection status on pattern of failure and survival after pancreaticoduodenectomy for pancreatic adenocarcinoma. Ann Surg 246: 52-60.PubMedCrossRef Raut CP, Tseng JF, Sun CC, Wang H, Wolff RA, et al. (2007) Impact of resection status on pattern of failure and survival after pancreaticoduodenectomy for pancreatic adenocarcinoma. Ann Surg 246: 52-60.PubMedCrossRef
11.
go back to reference Schmidt CM, Powell ES, Yiannoutsos CT, Howard TJ, Wiebke EA, et al. (2004) Pancreaticoduodenectomy: a 20-year experience in 516 patients. Arch Surg 139: 718-725; discussion 725-717. Schmidt CM, Powell ES, Yiannoutsos CT, Howard TJ, Wiebke EA, et al. (2004) Pancreaticoduodenectomy: a 20-year experience in 516 patients. Arch Surg 139: 718-725; discussion 725-717.
12.
go back to reference Neoptolemos JP, Stocken DD, Friess H, Bassi C, Dunn JA, et al. (2004) A randomized trial of chemoradiotherapy and chemotherapy after resection of pancreatic cancer. N Engl J Med 350: 1200-1210.PubMedCrossRef Neoptolemos JP, Stocken DD, Friess H, Bassi C, Dunn JA, et al. (2004) A randomized trial of chemoradiotherapy and chemotherapy after resection of pancreatic cancer. N Engl J Med 350: 1200-1210.PubMedCrossRef
13.
go back to reference Neoptolemos JP, Stocken DD, Bassi C, Ghaneh P, Cunningham D, et al. (2010) Adjuvant chemotherapy with fluorouracil plus folinic acid vs gemcitabine following pancreatic cancer resection: a randomized controlled trial. JAMA 304: 1073-1081.PubMedCrossRef Neoptolemos JP, Stocken DD, Bassi C, Ghaneh P, Cunningham D, et al. (2010) Adjuvant chemotherapy with fluorouracil plus folinic acid vs gemcitabine following pancreatic cancer resection: a randomized controlled trial. JAMA 304: 1073-1081.PubMedCrossRef
14.
go back to reference Verbeke CS (2008) Resection margins and R1 rates in pancreatic cancer--are we there yet? Histopathology 52: 787-796.PubMedCrossRef Verbeke CS (2008) Resection margins and R1 rates in pancreatic cancer--are we there yet? Histopathology 52: 787-796.PubMedCrossRef
15.
go back to reference Yeo CJ, Cameron JL, Lillemoe KD, Sitzmann JV, Hruban RH, et al. (1995) Pancreaticoduodenectomy for cancer of the head of the pancreas. 201 patients. Ann Surg 221: 721-731; discussion 731-723. Yeo CJ, Cameron JL, Lillemoe KD, Sitzmann JV, Hruban RH, et al. (1995) Pancreaticoduodenectomy for cancer of the head of the pancreas. 201 patients. Ann Surg 221: 721-731; discussion 731-723.
16.
go back to reference Khalifa MA (2007) Intraoperative assessment of the Whipple resection specimen. J Clin Pathol 60: 975-980.PubMedCrossRef Khalifa MA (2007) Intraoperative assessment of the Whipple resection specimen. J Clin Pathol 60: 975-980.PubMedCrossRef
17.
go back to reference Verbeke CS, Leitch D, Menon KV, McMahon MJ, Guillou PJ, et al. (2006) Redefining the R1 resection in pancreatic cancer. Br J Surg 93: 1232-1237.PubMedCrossRef Verbeke CS, Leitch D, Menon KV, McMahon MJ, Guillou PJ, et al. (2006) Redefining the R1 resection in pancreatic cancer. Br J Surg 93: 1232-1237.PubMedCrossRef
18.
go back to reference Esposito I, Kleeff J, Bergmann F, Reiser C, Herpel E, et al. (2008) Most pancreatic cancer resections are R1 resections. Ann Surg Oncol 15: 1651-1660.PubMedCrossRef Esposito I, Kleeff J, Bergmann F, Reiser C, Herpel E, et al. (2008) Most pancreatic cancer resections are R1 resections. Ann Surg Oncol 15: 1651-1660.PubMedCrossRef
19.
go back to reference (2003) Japanese Pancreatic Society: Classification of Pancreatic Cancer. Tokyo: Kanahara Publishing Co. (2003) Japanese Pancreatic Society: Classification of Pancreatic Cancer. Tokyo: Kanahara Publishing Co.
20.
go back to reference Hruban RH, Pitman MB, Klimstra DS (2007) Tumors of the pancreas. Atlas of tumor pathology. Washington DC: Armed Forces Institute of Pathology. Hruban RH, Pitman MB, Klimstra DS (2007) Tumors of the pancreas. Atlas of tumor pathology. Washington DC: Armed Forces Institute of Pathology.
21.
go back to reference Jamieson NB, Foulis AK, Oien KA, Going JJ, Glen P, et al. (2010) Positive mobilization margins alone do not influence survival following pancreatico-duodenectomy for pancreatic ductal adenocarcinoma. Ann Surg 251: 1003-1010.PubMedCrossRef Jamieson NB, Foulis AK, Oien KA, Going JJ, Glen P, et al. (2010) Positive mobilization margins alone do not influence survival following pancreatico-duodenectomy for pancreatic ductal adenocarcinoma. Ann Surg 251: 1003-1010.PubMedCrossRef
22.
go back to reference Schmidt CM, Glant J, Winter JM, Kennard J, Dixon J, et al. (2007) Total pancreatectomy (R0 resection) improves survival over subtotal pancreatectomy in isolated neck margin positive pancreatic adenocarcinoma. Surgery 142: 572-578; discussion 578-580. Schmidt CM, Glant J, Winter JM, Kennard J, Dixon J, et al. (2007) Total pancreatectomy (R0 resection) improves survival over subtotal pancreatectomy in isolated neck margin positive pancreatic adenocarcinoma. Surgery 142: 572-578; discussion 578-580.
23.
go back to reference Hernandez J, Mullinax J, Clark W, Toomey P, Villadolid D, et al. (2009) Survival after pancreaticoduodenectomy is not improved by extending resections to achieve negative margins. Ann Surg 250: 76-80.PubMedCrossRef Hernandez J, Mullinax J, Clark W, Toomey P, Villadolid D, et al. (2009) Survival after pancreaticoduodenectomy is not improved by extending resections to achieve negative margins. Ann Surg 250: 76-80.PubMedCrossRef
24.
go back to reference Williamson R (1994) The pancreas. In: Keen G, Farndon J, editors. Operative surgery and management. Oxford, England: Butterworth Heinemann. Williamson R (1994) The pancreas. In: Keen G, Farndon J, editors. Operative surgery and management. Oxford, England: Butterworth Heinemann.
25.
go back to reference Sommerville CA, Limongelli P, Pai M, Ahmad R, Stamp G, et al. (2009) Survival analysis after pancreatic resection for ampullary and pancreatic head carcinoma: an analysis of clinicopathological factors. J Surg Oncol 100: 651-656.PubMedCrossRef Sommerville CA, Limongelli P, Pai M, Ahmad R, Stamp G, et al. (2009) Survival analysis after pancreatic resection for ampullary and pancreatic head carcinoma: an analysis of clinicopathological factors. J Surg Oncol 100: 651-656.PubMedCrossRef
26.
go back to reference Pathologists TRCo (2010) Standards and Minimum Datasets for Reporting Cancers. Minimum Dataset for the Histopathological Reporting of Pancreatic, Ampulla of Vater and Bile Duct Carcinoma. London, UK. Pathologists TRCo (2010) Standards and Minimum Datasets for Reporting Cancers. Minimum Dataset for the Histopathological Reporting of Pancreatic, Ampulla of Vater and Bile Duct Carcinoma. London, UK.
27.
go back to reference Verbeke CS, Menon KV (2009) Redefining resection margin status in pancreatic cancer. HPB (Oxford) 11: 282-289.CrossRef Verbeke CS, Menon KV (2009) Redefining resection margin status in pancreatic cancer. HPB (Oxford) 11: 282-289.CrossRef
28.
go back to reference Angst E, Kim-Fuchs C, Kuruvilla YC, Inderbitzin D, Montani M, et al. (2012) How to counter the problem of R1 resection in duodenopancreatectomy for pancreatic cancer? J Gastrointest Surg 16: 673.PubMedCrossRef Angst E, Kim-Fuchs C, Kuruvilla YC, Inderbitzin D, Montani M, et al. (2012) How to counter the problem of R1 resection in duodenopancreatectomy for pancreatic cancer? J Gastrointest Surg 16: 673.PubMedCrossRef
29.
go back to reference Edge SB, Byrd DR, Compton CC, Fritz AG, Greene FL, et al. (2010) American Joint Committee on Cancer (AJCC) cancer staging manual. Chicago: Springer. Edge SB, Byrd DR, Compton CC, Fritz AG, Greene FL, et al. (2010) American Joint Committee on Cancer (AJCC) cancer staging manual. Chicago: Springer.
30.
go back to reference Howard TJ, Krug JE, Yu J, Zyromski NJ, Schmidt CM, et al. (2006) A margin-negative R0 resection accomplished with minimal postoperative complications is the surgeon’s contribution to long-term survival in pancreatic cancer. J Gastrointest Surg 10: 1338-1345; discussion 1345-1336. Howard TJ, Krug JE, Yu J, Zyromski NJ, Schmidt CM, et al. (2006) A margin-negative R0 resection accomplished with minimal postoperative complications is the surgeon’s contribution to long-term survival in pancreatic cancer. J Gastrointest Surg 10: 1338-1345; discussion 1345-1336.
31.
go back to reference Nagakawa T, Sanada H, Inagaki M, Sugama J, Ueno K, et al. (2004) Long-term survivors after resection of carcinoma of the head of the pancreas: significance of histologically curative resection. J Hepatobiliary Pancreat Surg 11: 402-408.PubMedCrossRef Nagakawa T, Sanada H, Inagaki M, Sugama J, Ueno K, et al. (2004) Long-term survivors after resection of carcinoma of the head of the pancreas: significance of histologically curative resection. J Hepatobiliary Pancreat Surg 11: 402-408.PubMedCrossRef
32.
go back to reference Tsuchiya R, Noda T, Harada N, Miyamoto T, Tomioka T, et al. (1986) Collective review of small carcinomas of the pancreas. Ann Surg 203: 77-81.PubMedCrossRef Tsuchiya R, Noda T, Harada N, Miyamoto T, Tomioka T, et al. (1986) Collective review of small carcinomas of the pancreas. Ann Surg 203: 77-81.PubMedCrossRef
33.
go back to reference Westgaard A, Tafjord S, Farstad IN, Cvancarova M, Eide TJ, et al. (2008) Resectable adenocarcinomas in the pancreatic head: the retroperitoneal resection margin is an independent prognostic factor. BMC Cancer 8: 5.PubMedCrossRef Westgaard A, Tafjord S, Farstad IN, Cvancarova M, Eide TJ, et al. (2008) Resectable adenocarcinomas in the pancreatic head: the retroperitoneal resection margin is an independent prognostic factor. BMC Cancer 8: 5.PubMedCrossRef
34.
go back to reference Chua TC, Saxena A (2010) Extended pancreaticoduodenectomy with vascular resection for pancreatic cancer: a systematic review. J Gastrointest Surg 14: 1442-1452.PubMedCrossRef Chua TC, Saxena A (2010) Extended pancreaticoduodenectomy with vascular resection for pancreatic cancer: a systematic review. J Gastrointest Surg 14: 1442-1452.PubMedCrossRef
35.
go back to reference Nakagohri T, Kinoshita T, Konishi M, Inoue K, Takahashi S (2003) Survival benefits of portal vein resection for pancreatic cancer. Am J Surg 186: 149-153.PubMedCrossRef Nakagohri T, Kinoshita T, Konishi M, Inoue K, Takahashi S (2003) Survival benefits of portal vein resection for pancreatic cancer. Am J Surg 186: 149-153.PubMedCrossRef
Metadata
Title
Tumor Infiltration in the Medial Resection Margin Predicts Survival After Pancreaticoduodenectomy for Pancreatic Ductal Adenocarcinoma
Authors
Yaojun Zhang
Adam E. Frampton
Patrizia Cohen
Charis Kyriakides
Jan J. Bong
Nagy A. Habib
Duncan R. C. Spalding
Raida Ahmad
Long R. Jiao
Publication date
01-10-2012
Publisher
Springer-Verlag
Published in
Journal of Gastrointestinal Surgery / Issue 10/2012
Print ISSN: 1091-255X
Electronic ISSN: 1873-4626
DOI
https://doi.org/10.1007/s11605-012-1985-4

Other articles of this Issue 10/2012

Journal of Gastrointestinal Surgery 10/2012 Go to the issue